RxDoctor Payments Data

Robert Husemann

Psychiatric/Mental Health · Dubuque, IANPI 1013639749

Payments from drug & device makers

$2,899in general payments, 2019–2025

Across 177 payments — averaging $16.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$468
  • AbbVie$360
  • Otsuka America Pharmaceutical, Inc.$345
  • Teva Pharmaceuticals USA, Inc.$339
  • Alkermes, Inc.$259
  • Johnson & Johnson$250
  • plus $878 from 11 others

What the payments were for

  • Food & beverage$2,87299%
  • Education$271%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,899 in reported general payments places this provider in the 80th percentile of 443 psychiatric/mental health providers in Iowa.

See all psychiatric/mental health providers in Iowa

Medicare billing

Part B allowed, 2024
$11,876
Medicare patients
56
Services billed
174

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate58$198,469
AustedoDeutetrabenazine14$77,719
Abilify MaintenaAripiprazole22$63,739
AristadaAripiprazole Lauroxil13$40,270
RexultiBrexpiprazole21$28,536
Risperdal ConstaRisperidone Microspheres12$23,408
TrintellixVortioxetine Hydrobromide30$14,974
Aripiprazole127$12,364
Divalproex Sodium ErDivalproex Sodium107$7,251
Duloxetine Hcl211$4,336
Adderall XrDextroamphetamine/Amphetamine19$4,075
Paliperidone ErPaliperidone25$4,043
Quetiapine Fumarate218$4,020
Asenapine Maleate16$3,631
Trazodone Hcl349$3,621

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Risperdal Consta$250$221,87770 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$345$92,27543 claims
Teva Pharmaceuticals USA, Inc.Austedo$339$77,71914 claims
Alkermes, Inc.Aristada$259$40,27013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 443 psychiatric/mental health providers in Iowa.

Other psychiatric/mental health in Dubuque

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →